Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intrapleural Bevacizumab Injection for Treating Malignant Pleural or Pericardial Effusion in Non-small Cell Lung Cancer

NCT02054052 is registered in ClinicalTrials.gov with Haihong Yang, MD, Pricipal investigator as lead sponsor.

NCT NCT02054052
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02054052 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intrapleural Bevacizumab Injection for Treating Malignant Pleural or Pericardial Effusion in Non-small Cell Lung Cancer
Lead sponsor
Haihong Yang, MD, Pricipal investigator
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2014
Completion date
March 31, 2019
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant pleural effusion, non-small cell lung cancer